Update: 17.09.2024
Last week: 36 week 2024 (02.09.2024 - 08.09.2024)
Last full month: August 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 747 | -6.9% | 13.2% | -0.5 | 14 348 374 | -7.0% | 9.2% | -0.4 | -3.5% |
| MoM | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| YTD | 264 427 | 21.7% | 11.7% | 2.9 | 558 134 489 | 38.1% | 9.4% | 2 | -8.5% |
| MAT | 388 020 | 24.5% | 11.0% | 2.3 | 810 826 405 | 41.1% | 9.0% | 1.7 | -1.3% |
| BRAINMAX | |||||||||
| WoW | 1 487 | -19.0% | 100.0% | 0 | 5 327 530 | -18.3% | 100.0% | 0 | -19.0% |
| MoM | 6 855 | 12.4% | 100.0% | 0 | 24 503 753 | 13.7% | 100.0% | 0 | 12.4% |
| YTD | 44 016 | 58.2% | 100.0% | 0 | 155 489 057 | 64.4% | 100.0% | 0 | 58.2% |
| MAT | 62 841 | 68.7% | 100.0% | 0 | 221 882 404 | 77.9% | 100.0% | 0 | 68.7% |
| GOLDLINE PLUS | |||||||||
| WoW | 13 817 | -3.1% | 46.3% | 1.1 | 43 248 412 | -1.9% | 38.3% | 1.7 | -5.4% |
| MoM | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| YTD | 598 836 | -5.0% | 45.0% | 0.6 | 1 884 402 446 | -2.4% | 36.8% | -2.8 | -6.3% |
| MAT | 837 250 | 0.2% | 45.4% | 0.8 | 2 644 852 607 | 4.9% | 37.7% | -2 | -1.5% |
| MIGRENIUM | |||||||||
| WoW | 9 152 | -18.5% | 0.4% | -0.1 | 3 072 644 | -17.7% | 0.6% | -0.1 | -5.1% |
| MoM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| YTD | 420 489 | -9.4% | 0.5% | -0.1 | 131 212 679 | 55.0% | 0.7% | 0.2 | 7.1% |
| MAT | 598 061 | -9.8% | 0.5% | -0.1 | 169 235 239 | 40.1% | 0.6% | 0.1 | 10.4% |
| MODELAX-N | |||||||||
| WoW | 24 175 | 2.6% | 20.2% | 0.8 | 11 387 703 | 3.4% | 13.2% | 0.4 | -1.4% |
| MoM | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| YTD | 1 033 697 | 31.5% | 22.6% | 3.8 | 448 858 078 | 80.7% | 14.5% | 4.1 | 9.1% |
| MAT | 1 415 497 | 47.4% | 21.3% | 4.8 | 583 327 097 | 89.9% | 13.3% | 4 | 14.2% |
| REDUXIN | |||||||||
| WoW | 9 407 | -11.1% | 31.5% | -2 | 48 730 121 | -11.6% | 43.1% | -2.6 | -5.4% |
| MoM | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| YTD | 437 374 | -8.1% | 32.9% | -0.7 | 2 333 142 124 | 12.8% | 45.6% | 3.2 | -6.3% |
| MAT | 599 087 | -5.3% | 32.5% | -1.3 | 3 137 791 920 | 16.2% | 44.7% | 2.2 | -1.5% |
| REDUXIN FORTE | |||||||||
| WoW | 3 088 | -0.7% | 10.3% | 0.5 | 13 203 040 | 0.3% | 11.7% | 0.8 | -5.4% |
| MoM | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| YTD | 118 904 | 0.3% | 8.9% | 0.6 | 513 494 486 | 12.5% | 10.0% | 0.7 | -6.3% |
| MAT | 166 351 | 7.9% | 9.0% | 0.8 | 710 700 630 | 19.8% | 10.1% | 0.8 | -1.5% |
| SALVISAR | |||||||||
| WoW | 10 844 | 16.7% | 1.5% | 0.3 | 4 619 485 | 17.5% | 1.3% | 0.2 | -4.1% |
| MoM | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
| YTD | 358 185 | 2.8% | 1.3% | 0.1 | 146 571 136 | 28.5% | 1.2% | 0.1 | -1.9% |
| MAT | 508 198 | -9.5% | 1.3% | -0.2 | 196 242 006 | 4.3% | 1.1% | -0.1 | 2.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 264 427 | 21.7% | 11.7% | 2.9 | 558 134 489 | 38.1% | 9.4% | 2 | -8.5% |
| BRAINMAX | 44 016 | 58.2% | 100.0% | 0 | 155 489 057 | 64.4% | 100.0% | 0 | 58.2% |
| GOLDLINE PLUS | 598 836 | -5.0% | 45.0% | 0.6 | 1 884 402 446 | -2.4% | 36.8% | -2.8 | -6.3% |
| MIGRENIUM | 420 489 | -9.4% | 0.5% | -0.1 | 131 212 679 | 55.0% | 0.7% | 0.2 | 7.1% |
| MODELAX-N | 1 033 697 | 31.5% | 22.6% | 3.8 | 448 858 078 | 80.7% | 14.5% | 4.1 | 9.1% |
| REDUXIN CAPS | 437 374 | -8.1% | 32.9% | -0.7 | 2 333 142 124 | 12.8% | 45.6% | 3.2 | -6.3% |
| REDUXIN FORTE | 118 904 | 0.3% | 8.9% | 0.6 | 513 494 486 | 12.5% | 10.0% | 0.7 | -6.3% |
| SALVISAR | 358 185 | 2.8% | 1.3% | 0.1 | 146 571 136 | 28.5% | 1.2% | 0.1 | -1.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 388 020 | 24.5% | 11.0% | 2.3 | 810 826 405 | 41.1% | 9.0% | 1.7 | -1.3% |
| BRAINMAX | 62 841 | 68.7% | 100.0% | 0 | 221 882 404 | 77.9% | 100.0% | 0 | 68.7% |
| GOLDLINE PLUS | 837 250 | 0.2% | 45.4% | 0.8 | 2 644 852 607 | 4.9% | 37.7% | -2 | -1.5% |
| MIGRENIUM | 598 061 | -9.8% | 0.5% | -0.1 | 169 235 239 | 40.1% | 0.6% | 0.1 | 10.4% |
| MODELAX-N | 1 415 497 | 47.4% | 21.3% | 4.8 | 583 327 097 | 89.9% | 13.3% | 4 | 14.2% |
| REDUXIN CAPS | 599 087 | -5.3% | 32.5% | -1.3 | 3 137 791 920 | 16.2% | 44.7% | 2.2 | -1.5% |
| REDUXIN FORTE | 166 351 | 7.9% | 9.0% | 0.8 | 710 700 630 | 19.8% | 10.1% | 0.8 | -1.5% |
| SALVISAR | 508 198 | -9.5% | 1.3% | -0.2 | 196 242 006 | 4.3% | 1.1% | -0.1 | 2.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 747 | -6.9% | 13.2% | -0.5 | 14 348 374 | -7.0% | 9.2% | -0.4 | -3.5% |
| BRAINMAX | 1 487 | -19.0% | 100.0% | 0 | 5 327 530 | -18.3% | 100.0% | 0 | -19.0% |
| GOLDLINE PLUS | 13 817 | -3.1% | 46.3% | 1.1 | 43 248 412 | -1.9% | 38.3% | 1.7 | -5.4% |
| MIGRENIUM | 9 152 | -18.5% | 0.4% | -0.1 | 3 072 644 | -17.7% | 0.6% | -0.1 | -5.1% |
| MODELAX-N | 24 175 | 2.6% | 20.2% | 0.8 | 11 387 703 | 3.4% | 13.2% | 0.4 | -1.4% |
| REDUXIN CAPS | 9 407 | -11.1% | 31.5% | -2 | 48 730 121 | -11.6% | 43.1% | -2.6 | -5.4% |
| REDUXIN FORTE | 3 088 | -0.7% | 10.3% | 0.5 | 13 203 040 | 0.3% | 11.7% | 0.8 | -5.4% |
| SALVISAR | 10 844 | 16.7% | 1.5% | 0.3 | 4 619 485 | 17.5% | 1.3% | 0.2 | -4.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| BRAINMAX | 6 855 | 12.4% | 100.0% | 0 | 24 503 753 | 13.7% | 100.0% | 0 | 12.4% |
| GOLDLINE PLUS | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| MIGRENIUM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| MODELAX-N | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| REDUXIN CAPS | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| REDUXIN FORTE | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| SALVISAR | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs